INTRODUCTION
According to National Comprehensive Cancer Network (NCCN) guidelines, early enrollment in hospice maximizes potential benefits and should be emphasized. 1 As for the timing of referral, patients become eligible when their life expectancy is 6 months, and physicians and policy experts indicate that patients should ideally spend approximately 2 to 3 months in hospice. [2] [3] [4] Despite this guidance, hospice referrals often occur too late in the disease trajectory to improve quality of life for patients with cancer. 5 More recently, the use of hospice and earlier enrollment have become important quality metrics in cancer care 6, 7 because enrollment can improve physical and psychological symptoms, enhance caregiver well-being, and reduce hospitalizations and in-hospital deaths. 8, 9 Hospice use among Medicare beneficiaries is increasing, but late enrollment, defined as enrollment within the last 3 days of life, more than doubled from 2000 to 2009. 10 Other observed trends, including increases in hospitalizations, transitions in care, and intensive care unit admissions, underscore the continued use of aggressive treatment at the end of life. 10 Similarly, a Dartmouth Atlas report noted among Medicare beneficiaries with cancer an increase in those who saw 10 or more physicians or were receiving life-sustaining treatments in the last month of life. 11 In addition to these trends, considerable geographic region variability in hospice use exists, 12 even among academic and National Cancer Institute-designated medical centers. 11 The mechanisms that contribute to these regional trends are not well understood, but they are unlikely to be explained by patient preferences. 13 Early hospice enrollment and reduced use of high-intensity endof-life care are both associated with improved patient and family perceptions of the quality of care. 14, 15 In an effort to improve end-of-life care, the Veterans Health Administration (VA) has created the Hospice and Palliative Care Program Office and mandated that all medical centers have a palliative care consultation team. The VA instituted a comprehensive end-of-life care initiative designed to increase access to palliative care services and local facility collaboration with community hospice programs. 16 Aspects unique to VA health care, such as the financial structure, may contribute to improved hospice use because financial incentives for high-intensity care are absent. 17 Veterans may also receive concurrent disease-modifying treatment while they are in hospice 18 in contrast to non-VA Medicare patients, and this may affect enrollment. Although a sizable percentage of veterans with cancer were reported to receive hospice care in 2012, 19 trends in use, including the timing of enrollment, are unexplored.
We analyzed temporal and regional trends in hospice use, the timing of enrollment, and patient characteristics that contribute to use in this national, integrated health care system. The study cohort was composed of patients with advanced-stage lung cancer because this is the leading cause of cancer death among both men and women in the United States.
MATERIALS AND METHODS
In this retrospective cohort study, using the Veterans Affairs Central Cancer Registry (VACCR), we identified all decedents with advanced-stage lung cancer (stages IIIB and IV) diagnosed from January 2007 to June 2013. 20 Patients with nonprimary lung cancer or an unknown stage or histology were excluded. The VACCR receives and stores information on cancer diagnoses and treatments compiled by local cancer registry staff at each of the 132 VA medical centers that diagnose and/or treat veterans with cancer. Adhering to the standards of the Commission on Cancer, 21 VACCR staff perform case identification and abstraction of variables. Registry data include extensive demographics, cancer identification, disease staging, and treatments received among other variables. Sociodemographic characteristics at the time of the lung cancer diagnosis were also compiled from the VA Corporate Data Warehouse, which is a centralized clinical data storage platform. Cancer-specific characteristics, such as stage, were determined by VACCR registrars with the American Joint Committee on Cancer staging system. See the online supporting information for additional details regarding patient characteristics, facility regions, and disease-modifying treatments received (VA institutional review board approval 00010985).
Hospice Use
The date of hospice enrollment was determined from several sources, including VA Fee Basis files through bed section codes, clinic stop codes, and International Classification of Diseases, Ninth Revision, Clinical Modification codes. 19 For care purchased outside the VA, we used VA Purchased Care claim files via visit or Health Care Finance Administration codes. 19 Using Part A and B claims, we used Medicare claims data through the Medicare hospice file data set. 10 The VA Medicare hospice file was available through December 2013, and because of potential billing delays after the date of receipt, the cohort was censored to those diagnosed before June 30, 2013.
Statistical Analysis
Descriptive statistics were used to characterize patient characteristics by hospice enrollment; continuous data are presented as means and standard deviations or as medians and interquartile ranges, and categorical variables are presented as proportions. Patient characteristics associated with enrollment or late hospice enrollment were analyzed through multivariable logistic regression with backward stepwise selection; the final models were adjusted for age, sex, race/ethnicity, marital status, income, Functional Comorbidity Index, 22 Charlson Comorbidity Index, 23 cancer stage and histology, and year of diagnosis. Logistic regression was used to model hospice enrollment, enrollment in the last month of life, and enrollment in the last 3 days of life. Cox proportional hazards were used to model the time from the cancer diagnosis to hospice enrollment. The annual trend was estimated with a year variable in each model. All models were adjusted for the same covariates identified in the patient characteristics models except for the year of diagnosis. Regional differences in hospice use were analyzed with multivariable logistic regression adjusted for the same covariates identified in the patient characteristic models; estimated marginal means are presented. The Northeast region was used as a reference group because of its sample size and lowest enrollment. All modeling used robust standard errors, and statistical testing was 2-sided with a threshold of P < .05. All analyses were performed with Stata 14 (StataCorp).
RESULTS
From 2007 to 2013, 21,860 patients died with advancedstage lung cancer in the Veterans Affairs Health Care System. The mean age was 68 years, 98% were men, 70% were white, 57% were not married, and 68% were Medicare beneficiaries at the time of their cancer diagnosis ( Table 1) . As for lung cancer characteristics, 89% had stage IV disease, and 69% had non-small cell lung cancer. The median survival time from cancer diagnosis was 134 days (interquartile range, 51-307 days), and it was similar when it was stratified by the year of diagnosis. In this cohort, 70.3% of the patients were enrolled in hospice care (Table 2 ). Patients enrolled in hospice spent a median of 27 days (interquartile range, 8-76 days) in hospice before death. The mean time from lung cancer diagnosis to hospice enrollment was 183 days (standard deviation, 256.1 days; median, 86 days; interquartile 
Regional Variation in Use
Regional variability in hospice enrollment existed nationally and ranged from 63.9% in the Northeast to 77.0% in the Southeast; these differences were significant (P < .01; Table 3 ). The mean number of days in hospice during the last month of life was significantly different across regions and ranged from 18.9 to 20.6 days. Regional variability in the timing of hospice enrollment was significant; enrollment in the last month of life ranged from 50.0% in the Southeast to 55.6% in the Northeast. Enrollment in the last 3 days of life ranged from 11.5% in the Southeast to 17.8% in the Northeast. Chemotherapy receipt in the last 2 weeks of life ranged from 11.3% to 13.3% and was not significantly different across regions. Hospice enrollment trends over time increased similarly across regions.
Patient Characteristics
Hospice enrollment was associated with older age (AOR, 1.01; P < .001), moderate income versus low income (AOR, 1.12; P 5 .002), a higher Functional Comorbidity Index score (AOR, 1.02; P < .001), and stage IV lung cancer (AOR, 1.31; P < .001; Table 4 ). Black race (AOR, 0.78; P < .001), an unmarried marital status (AOR, 0.80; P < .001), a lower Charlson Comorbidity Index score (AOR, 0.98; P < .001), small cell lung cancer (AOR, 0.85; P < .001), and other histologies (AOR, 0.91; P 5 .03) were all associated with decreased hospice enrollment. The home residence location and tobacco history were not associated with hospice enrollment. Male sex (AOR, 1.76; P 5 .006), a higher Charlson Comorbidity Index score (AOR, 1.04; P < .001), small cell lung cancer (AOR, 1.23; P < .001), and other lung cancer histologies (AOR, 1.15; P 5 .04) were associated with late hospice enrollment (3 days). Older age was associated with a decreased likelihood of late hospice enrollment (AOR, 0.98; P < .001).
DISCUSSION
This is the largest, most comprehensive study examining hospice use in a national, integrated health system. We observed increased trends in overall and, more importantly, earlier hospice enrollment among patients with advanced lung cancer over time. The considerable geographic variability in hospice use and the patient characteristics that were associated with the use and timing of hospice enrollment provide a framework for focused efforts to enhance utilization. Encouraging trends in timely hospice enrollment were identified in the VA; however, opportunities for improvement in end-of-life care exist. Determining health care system-related factors that can improve the quality of cancer care, such as timely hospice enrollment, deserves more attention. The improvements in overall hospice enrollment and the timing of hospice enrollment that we observed may be related to factors unique to the VA system or may be products of an integrated health care delivery model. 24 VA end-of-life care initiatives over the past decade, such as its comprehensive end-of-life care initiative, have affected hospice availability, which contributes to utilization. 25 More importantly, these VA initiatives may have contributed to a culture change within the system because physician and hospital practice styles are major drivers of Original Article end-of-life care, 26, 27 as are physicians' attitudes regarding hospice referrals. 28 Additional aspects of the VA system may increase hospice use; these include the lack of financial incentives for aggressive end-of-life care and the ability of veterans to receive disease-modifying treatment while they are in hospice. 18 Finally, integrated health care within the VA may enhance the timeliness of hospice enrollment among cancer patients, as was observed in another integrated system, Kaiser Permanente of Northern California. 29 Patients report issues with care coordination and communication related to health care system disorganization, and patients favor integrated care models. 30 Breakdowns in patient-clinician communication in nonintegrated settings may contribute to patients' unrealistic expectations and a desire for aggressive care at the end of life, 31, 32 and this may delay or decrease hospice use.
The decreasing trend in late enrollment that we observed is particularly meaningful because early use of hospice is lauded as a cancer care quality metric, 6, 7 and the Center for Medicare and Medicaid Services has begun implementing nationally endorsed hospice quality measures based on the timing of enrollment. 33 Despite the potential benefits of hospice enrollment, 8, 9 Medicare beneficiaries in non-VA settings continue to experience worsening trends in short hospice stays. 10, 11 Among cancer decedents, hospice enrollment of approximately 2 months is suggested to maximize value and take advantage of the multidisciplinary approach. [2] [3] [4] Patients and their families report greater benefits from longer stays, and those approximately 2 weeks in length have been perceived as coming too late. 2, 3 Although the overall trend in late enrollment is decreasing within the VA, 1 in 7 patients still experienced 3 days of hospice care. Short hospice stays may be justified if they are related to sudden medical deterioration or patient preferences. 34 Concurrent use of disease-modifying therapy and its related toxicities may contribute to sudden deterioration and an increased likelihood of short hospice stays within the VA. Reasons for late hospice enrollment deserve further exploration, which will likely require an analysis of patient-level data.
Despite the systematic organization and culture within the VA, this system was not immune to the significant geographic variability in hospice use seen in non-VA settings. 35 There is a high concentration of Medicarecertified hospices in the Southeast region of the United States, which may contribute to increased use. 36 A direct relationship exists between the supply and utilization/ intensity of health care. 37, 38 This can translate to more aggressive care at the end of life because hospice use is higher in areas with fewer inpatient hospital beds per capita. 39 Increased end-of-life care intensity is associated with very short hospice stays. 40 Hospital capacity and physician capacity are highest in the Northeast among VA and non-VA settings, and this potentially contributes to increased end-of-life care intensity. 41 Although hospice variability within a health system is not entirely surprising, the variation in use was not explained by differences in the major components of the health care infrastructure; instead, it was attributed to local factors such as community leadership on end-of-life issues. 42 Overall, the trends in hospice use that we observed were encouraging and likely contribute to the reduction in aggressive end-of-life care observed in veterans in comparison with fee-for-service Medicare beneficiaries. 17 Patient characteristics affected hospice enrollment and were similar to those in non-VA settings with a few 35, 43 and this is likely related to health care access. However, extreme economic hardship (ie, limited resources for caregiving) is associated with a preference for comfort care. 44 Our results were mixed regarding income, suggesting that income may be a less significant determinant of end-of-life care when health care access is not income-dependent. Surprisingly, patients with a greater number of comorbidities or more severe comorbidities (via the Charlson Comorbidity Index) were less likely to be enrolled and were more likely to be enrolled late in hospice. This potentially demonstrates the contribution of comorbid disease to unexpected, sudden deterioration in lung cancer patients. The timing of the comorbidity measurement (eg, precancer diagnosis) can affect differences in measured hospice use. 45 It is unknown whether patients' characteristics affect their care preferences or clinicians' referral patterns are biased; however, these patient subgroups should be targeted for interventions to increase hospice enrollment.
This study has limitations. The VACCR is limited to veterans who are diagnosed or receive cancer care within the VA. Patients enrolled in hospice at the time of their lung cancer diagnosis were excluded because our objective was to study hospice use related to lung cancer; overall enrollment was thus likely underestimated. Patients who were offered hospice by clinicians but chose not to enroll would have affected results in unpredictable ways. Reasons for not offering hospice, from clinicians' perspectives, were not explored. The place of residence, such as a nursing home, is associated with short hospice stays and was not studied. 46 Regional differences in hospice enrollment may be partially explained by patients' cultural, religious, or personal beliefs; however, these are unlikely to account for significant variation. 13 Regional differences in hospice use may be affected by availability, and patients' regional categorization was based on the reporting facility at diagnosis and did not account for migration.
In conclusion, within the Veterans Affairs Health Care System, overall and earlier hospice enrollment increased over time among patients with advanced-stage lung cancer. Significant regional variability in hospice enrollment exists, and this suggests opportunities for improvement. Future studies should focus on identifying regional processes and discrete elements of health care systems, such as financial or service models, that contribute to timely hospice use. The extrapolation of these elements to settings with decreased or delayed hospice enrollment is essential for reversing the current dismal trends in end-oflife care in the U.S.
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